Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• S(N)1-type alkylating agents are chemotherapeutics with unknown cytotoxicity mechanisms.
• Their toxicity is linked to the mismatch repair (MMR) system's processing of O(6)-methylguanine ((6Me)G)-containing mispairs.
• MMR-deficient cells show high resistance to these agents, highlighting MMR's role.

Purpose of the Study:

• To investigate the role of the MMR system in alkylating agent-induced cytotoxicity.
• To understand the molecular mechanisms of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) toxicity in human cells.
• To elucidate the cell cycle arrest and DNA damage response pathways involved.

Main Methods:

• Comparing MMR-proficient and MMR-deficient human cells.
• Treating cells with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
• Analyzing cell cycle progression, DNA damage response signaling (ATM, ATR, CHK1), and protein foci formation (gamma-H2AX, RPA).

Main Results:

• MNNG induced a cell cycle arrest dependent on functional MMR.
• The arrest occurred specifically in the second G(2) phase post-treatment.
• ATR and CHK1, but not ATM, were crucial for the MNNG-induced G(2) arrest.
• Nuclear foci of ATR, gamma-H2AX, and RPA indicated persistent DNA damage.

Conclusions:

• Functional MMR is essential for MNNG-induced G(2) cell cycle arrest.
• The ATR-CHK1 pathway, not ATM, mediates this MMR-dependent arrest.
• Persistent nuclear foci suggest MNNG induces irreparable DNA damage, contributing to cytotoxicity.